ZMYND10 and nasopharyngeal carcinoma: We have shown that re-expression of BLU in NPC, esophageal cancer derived cells inhibits the pathways of JNK and ERK of MAPK family, downregulating the kinase catalyzing protein phosphorylation modification [16]; the axis of MAPK-cyclin D was inhibited, and the cells arrested at G1 phase.